Chemical Compound
Fmoc-L-Thr(beta-D-GlcNAc(Ac)3)-OH
CAS Registry Number
160168-40-1
Primary Record
Fmoc-L-Thr(beta-D-GlcNAc(Ac)3)-OH
- In stock
- 6,080 g
- Purity
- 98.5 %
- CAS
- 160168-40-1
Compound Identifiers & Properties
- CAS
- 160168-40-1
- PubChem CID
- 14410190
- SMILES
- C[C@H]([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C
- Canonical SMILES
- CC(=O)N[C@H]1[C@H](O[C@H](C)[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
Names & Synonyms
- Fmoc-L-Thr(beta-D-GlcNAc(Ac)3)-OH
- GlcNAc L-threonine
- 160168-40-1
- GALNAC L-THREONINE
- C33H38N2O13
- Fmoc-Thr(GlcNAc(Ac)--D)-OH
- MFCD08274532
- OXLCJWGAUPPZQJ-WPYJLJGXSA-N
- EX-A3854
- Fmoc-L-Thr(|A-D-GlcNAc(Ac)3)-OH
- Fmoc-Thr(GlcNAc(Ac)3-?-D)-OH
- AG1006
- Fmoc-Thr(GlcNAc(Ac)3-beta-D)-OH
- AKOS037648919
- Fmoc-L-Thr(ss-D-GlcNAc(Ac)3)-OH
- ZINC150379907
- BAT-015387
- Fmoc-L-Thr(Beta-D-GlcN/Ac(Ac)3)-OH
- BS-16025
- MF111403
- CS-0186052
- FMOC-L-THR(| cent-D-GLCNAC(AC)3)-OH
- J1.906.112D
- D80724
- A934820
- (2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanoic acid
- 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranosyl-Fmoc threonine
- (2S,3R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid
- 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-?-D-glucopyranosyl-Fmoc threonine
- (2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanoicacid
- (2S,3R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydropyran-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid
- (2S,3R)-3-{[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxy methyl)tetrahydro-2H-pyran-2-yl]oxy}-2-{[(9H-fluoren-9-ylmethoxy) carbonyl]amino}butanoic acid (non-preferred name)
- (2S,3R)-3-{[(2R,3R,4R,5S,6R)-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-acetamidooxan-2-yl]oxy}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoic acid
- (2S,3R)-3-{[(2R,3R,4R,5S,6R)-4,5-BIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]-3-ACETAMIDOOXAN-2-YL]OXY}-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}BUTANOIC ACID
- N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)-L-threonine
- N-(9H-Fluorene-9-ylmethoxycarbonyl)-O-[2-(acetylamino)-3-O,4-O,6-O-triacetyl-2-deoxy-beta-D-glucopyranosyl]-L-threonine
- N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-threonine (Fmoc-L-Thr(beta-D-GlcNAc(Ac)3)-OH)
- O-[3-O,4-O,6-O-Triacetyl-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-N-Fmoc-L-threonine